Surrozen picks up $50 mln Series B

South San Francisco-based Surrozen Inc., a biopharmaceutical company, has secured $50 million in Series B financing. The investors included Horizons Ventures, Hartford HealthCare Endowment, NS Investment and the Column Group.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!